Norden Gregory (CIK 1405104) reported 14 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy PRAX (1,371 shares), Buy RPRX (4,545 shares), Sell RPRX (3,045 shares), Sell ZTS (1,213 shares), Buy ZTS (1,619 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Praxis Precision Medicines, Inc. (PRAX) | Director | Buy | 1,371 | $0 |
| 2026-06-08 | Royalty Pharma plc (RPRX) | Director | Buy | 4,545 | $0 |
| 2026-05-15 | Royalty Pharma plc (RPRX) | Director | Sell | 3,045 | $161,385 |
| 2026-03-10 | Zoetis Inc. (ZTS) | Director | Sell | 1,213 | $0 |
| 2026-02-23 | Zoetis Inc. (ZTS) | Director | Buy | 1,619 | $0 |
| 2026-02-23 | Zoetis Inc. (ZTS) | Director | Sell | 406 | $51,676 |
| 2025-08-11 | Royalty Pharma plc (RPRX) | Director | Buy | 144,660 | $0 |
| 2025-08-11 | Royalty Pharma plc (RPRX) | Director | Sell | 33,500 | $1.2M |
| 2025-05-14 | Royalty Pharma plc (RPRX) | Director | Buy | 7,614 | $0 |
| 2025-02-18 | Zoetis Inc. (ZTS) | Director | Sell | 1,843 | $0 |
| 2025-02-11 | Zoetis Inc. (ZTS) | Director | Buy | 1,225 | $0 |
| 2025-02-11 | Zoetis Inc. (ZTS) | Director | Sell | 308 | $52,800 |
| 2025-02-10 | Zoetis Inc. (ZTS) | Director | Buy | 1,236 | $0 |
| 2025-02-10 | Zoetis Inc. (ZTS) | Director | Sell | 310 | $53,977 |
Source: SEC Form 4 filings · as of 2026-06-12